Machine-Learning-Based Prediction of Long-Term Efficacy of Nemolizumab: Post Hoc Analysis of Pooled Data from Two Phase III Clinical Trials - Poll - MDSpire

Machine-Learning-Based Prediction of Long-Term Efficacy of Nemolizumab: Post Hoc Analysis of Pooled Data from Two Phase III Clinical Trials

  • By

  • Makoto Kawashima

  • Tomoya Maeda

  • Kotaro Iwasaki

  • Masashi Takizawa

  • Noriaki Kaneda

  • Kenji Kabashima

  • May 15, 2026

  • 0 min

Share

Original Source(s)

Machine-Learning-Based Prediction of Long-Term Efficacy of Nemolizumab: Post Hoc Analysis of Pooled Data from Two Phase III Clinical Trials

  • by Makoto Kawashima, Tomoya Maeda, Kotaro Iwasaki, Masashi Takizawa, Noriaki Kaneda, Kenji Kabashima

  • May 15, 2026

Related Content

Blood Test Predicts Immunotherapy Response

AI-based analysis of blood DNA maps the complex ecosystem surrounding cancer cells

  • May 18, 2026

  • 3 min
Giant rapidly involuting congenital hemangioma in a neonate: a case report

Intercellular mitochondrial transfer in melanoma progression and therapeutic resistance: mechanisms and targeting potential